amiodarone has been researched along with Pleural Effusion in 18 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Pleural Effusion: Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
Excerpt | Relevance | Reference |
---|---|---|
"Pleural effusion is an uncommon manifestation of amiodarone toxicity and is usually associated with amiodarone-induced interstitial pneumonitis." | 8.86 | Amiodarone-induced loculated pleural effusion: case report and review of the literature. ( Alalawi, R; Nugent, K; Raj, R; Uong, V, 2010) |
"A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 7.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
" We describe an unusual manifestation of amiodarone-induced pulmonary toxicity in a patient with bilateral exudative pleural effusions and toxic involvement of other organs." | 5.27 | Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions. ( Franzini, DA; Gonzalez-Rothi, RJ; Hannan, SE; Hood, CI, 1987) |
" Treatment with amiodarone may lead to changes in thyroid tests results and to development of hypothyroidism or thyrotoxicosis." | 4.82 | [Thyroid and cardiovascular disorders]. ( Gajek, J; Zyśko, D, 2004) |
"Atypical manifestations of pulmonary toxicity and previously unreported autonomic nervous system dysfunction complicating amiodarone therapy were observed in a patient being treated for sustained ventricular tachycardia." | 4.77 | Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature. ( Estes, NA; Mack, KD; Manolis, AS; Tordjman, T, 1987) |
"Atrial fibrillation occurs frequently after lung transplantation and is commonly treated with amiodarone." | 3.74 | Amiodarone pulmonary toxicity after lung transplantation. ( Arrossi, A; Budev, M; Diaz-Guzman, E; Kanne, JP; Mireles-Cabodevila, E, 2008) |
"We report a case with typical clinical features of drug-induced lupus erythematosus, together with verrucous endocarditis and pleuropericardial effusion, due to amiodarone treatment." | 3.71 | Drug-induced lupus erythematosus by amiodarone. ( Schäfer, U; Schnabel, A; Sheikhzadeh, A, 2002) |
"We present a patient who developed a unilateral, exudative pleural effusion without concomitant pulmonary parenchymal disease while being treated with amiodarone." | 3.69 | Lymphocytic pleural exudate in a patient receiving amiodarone. ( Carmichael, LC; Newman, JH, 1996) |
"A patient receiving amiodarone for longstanding ventricular dysrhythmias presented with idiopathic chylothorax." | 3.68 | Chylous transport of amiodarone. ( Dryzer, SR; Nicolau, DP; Strange, C, 1992) |
"A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 3.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
" However, it has a wide profile of adverse effects involving a number of organ systems." | 1.28 | Amiodarone pulmonary toxicity--three unusual manifestations. ( Firouz-Abadi, A; McNeil, KD; Oliver, W; Zimmerman, PV, 1992) |
" We describe an unusual manifestation of amiodarone-induced pulmonary toxicity in a patient with bilateral exudative pleural effusions and toxic involvement of other organs." | 1.27 | Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions. ( Franzini, DA; Gonzalez-Rothi, RJ; Hannan, SE; Hood, CI, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (33.33) | 18.7374 |
1990's | 4 (22.22) | 18.2507 |
2000's | 6 (33.33) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diaz-Guzman, E | 1 |
Mireles-Cabodevila, E | 1 |
Arrossi, A | 1 |
Kanne, JP | 1 |
Budev, M | 1 |
Uong, V | 1 |
Nugent, K | 1 |
Alalawi, R | 1 |
Raj, R | 1 |
Yaşar Bilge, NS | 1 |
Gönüllü, E | 1 |
Kaşifoğlu, T | 1 |
Korkmaz, C | 1 |
Malhotra, A | 1 |
Muse, VV | 1 |
Mark, EJ | 1 |
Zyśko, D | 1 |
Gajek, J | 1 |
Pinto Marín, A | 1 |
Ríos Blanco, JJ | 1 |
García de Paso Mora, P | 1 |
Pascual Pareja, JF | 1 |
Mateos, M | 1 |
Sendino Revuelta, A | 1 |
Vázquez Rodríguez, JJ | 1 |
Maheshwari, M | 1 |
Baid, JC | 1 |
Vijayvergia, A | 1 |
Carmichael, LC | 1 |
Newman, JH | 1 |
Verswijvel, G | 1 |
Franssens, Y | 1 |
Deraemaeker, L | 1 |
Leyssens, G | 1 |
Govaerts, E | 1 |
Theunissen, P | 1 |
Sheikhzadeh, A | 1 |
Schäfer, U | 1 |
Schnabel, A | 1 |
McNeil, KD | 1 |
Firouz-Abadi, A | 1 |
Oliver, W | 1 |
Zimmerman, PV | 1 |
Strange, C | 1 |
Nicolau, DP | 1 |
Dryzer, SR | 1 |
White, JP | 1 |
Ward, MJ | 1 |
Akoun, GM | 1 |
Milleron, BJ | 1 |
Badaro, DM | 1 |
Mayaud, CM | 1 |
Liote, HA | 1 |
Manolis, AS | 1 |
Tordjman, T | 1 |
Mack, KD | 1 |
Estes, NA | 1 |
Paredes, R | 1 |
Gonzalez-Rothi, RJ | 1 |
Hannan, SE | 1 |
Hood, CI | 1 |
Franzini, DA | 1 |
Clarke, B | 1 |
Ward, DE | 1 |
Honey, M | 1 |
4 reviews available for amiodarone and Pleural Effusion
Article | Year |
---|---|
Amiodarone-induced loculated pleural effusion: case report and review of the literature.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Child; Female; Humans | 2010 |
[Thyroid and cardiovascular disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Artery B | 2004 |
Drug-induced adverse pulmonary reactions.
Topics: Amiodarone; Asthma; Bleomycin; Carmustine; Drug-Related Side Effects and Adverse Reactions; Gold; Hu | 1985 |
Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature.
Topics: Aged; Amiodarone; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Hypote | 1987 |
14 other studies available for amiodarone and Pleural Effusion
Article | Year |
---|---|
Amiodarone pulmonary toxicity after lung transplantation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypass; Humans; Lung Transp | 2008 |
Amiodarone-induced pleural fluid is not always accompanied by a risk factor.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Humans; Ma | 2012 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2003. An 82-year-old man with dyspnea and pulmonary abnormalities.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Bundle | 2003 |
[Left pleural effusion in patient with heart failure].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hypothyroidism | 2006 |
Amiodarone related rare toxicity in a burn patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Burns; Humans; Hyponatremia; Male; Pl | 2007 |
Lymphocytic pleural exudate in a patient receiving amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Humans; Male; Middle Aged; Pleural Eff | 1996 |
Amiodarone induced pulmonary toxicity.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aspartate Aminotr | 1998 |
Drug-induced lupus erythematosus by amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antibodies, Antinuclear; C-Reactive Pr | 2002 |
Amiodarone pulmonary toxicity--three unusual manifestations.
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Humans; Lung Diseases; Male; Middle Aged; Pleural Effusio | 1992 |
Chylous transport of amiodarone.
Topics: Aged; Amiodarone; Chyle; Chylothorax; Humans; Male; Pleural Effusion | 1992 |
Pleural T-lymphocyte subsets in amiodarone-associated pleuropneumonitis.
Topics: Aged; Alveolitis, Extrinsic Allergic; Amiodarone; Bronchoalveolar Lavage Fluid; Humans; Male; Pleura | 1989 |
[Pulmonary damage by drugs].
Topics: Amiodarone; Amphotericin B; Humans; Lung; Pleural Effusion; Pulmonary Edema; Pulmonary Fibrosis | 1987 |
Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions.
Topics: Amiodarone; Humans; Lung; Male; Middle Aged; Pleura; Pleural Effusion; Pleurisy | 1987 |
Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Benzofurans; Combined Modality Therapy; Exer | 1985 |